Peijia Medical Limited
HKEX:9996.HK
3.85 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 441.126 | 250.833 | 136.534 | 38.655 | 18.699 | 0 |
| Cost of Revenue
| 115.756 | 74.632 | 40.88 | 13.432 | 6.686 | 0 |
| Gross Profit
| 325.37 | 176.201 | 95.654 | 25.223 | 12.013 | 0 |
| Gross Profit Ratio
| 0.738 | 0.702 | 0.701 | 0.653 | 0.642 | 0 |
| Reseach & Development Expenses
| 293.42 | 383.651 | 454.424 | 109.442 | 55.134 | 27.851 |
| General & Administrative Expenses
| 141.637 | 123.432 | 114.425 | 117.972 | 43.73 | 8.613 |
| Selling & Marketing Expenses
| 324.981 | 241.63 | 93.252 | 21.126 | 7.482 | 0 |
| SG&A
| 466.618 | 365.062 | 207.677 | 139.098 | 51.212 | 8.613 |
| Other Expenses
| -3.908 | 2.321 | -1.522 | 0.541 | 128.037 | 1.167 |
| Operating Expenses
| 756.13 | 618.749 | 694.455 | 2,131.09 | 234.383 | 71.655 |
| Operating Income
| -430.76 | -322.846 | -235.869 | -208.724 | -222.37 | -70.222 |
| Operating Income Ratio
| -0.977 | -1.287 | -1.728 | -5.4 | -11.892 | 0 |
| Total Other Income Expenses Net
| 39.259 | 44.313 | 24.585 | -1,664.939 | -305.054 | -12.654 |
| Income Before Tax
| -391.501 | -398.235 | -574.216 | -2,068.656 | -531.977 | -82.876 |
| Income Before Tax Ratio
| -0.888 | -1.588 | -4.206 | -53.516 | -28.449 | 0 |
| Income Tax Expense
| 1.052 | 9.574 | 23.019 | 17.648 | 309.287 | 8.193 |
| Net Income
| -392.525 | -407.809 | -574.216 | -2,068.656 | -841.264 | -82.625 |
| Net Income Ratio
| -0.89 | -1.626 | -4.206 | -53.516 | -44.99 | 0 |
| EPS
| -0.58 | -0.61 | -0.87 | -4.43 | -1.38 | -0.14 |
| EPS Diluted
| -0.58 | -0.61 | -0.87 | -4.43 | -1.38 | -0.14 |
| EBITDA
| -290.257 | -359.905 | -212.613 | -190.87 | -209.351 | -67.129 |
| EBITDA Ratio
| -0.79 | -1.165 | -1.557 | -4.938 | -11.196 | 0 |